Skip to content
Ideas & intellectual property

Did showing, selling or crowdfunding your invention destroy your patent rights?

The rule people half-remember is that you get a year. There is a year. It is in 35 U.S.C. § 102(b)(1), it runs backwards from your filing date rather than forwards from the disclosure, it forgives only disclosures that came from you, and it is a rule of United States law that most of the rest of the world does not have. Almost every expensive mistake here comes from assuming the year is wider than those four conditions make it.

10 min readPublished How we write these

The short version

  • Section 102(a)(1) bars a patent where the invention was patented, described in a printed publication, in public use, on sale, or otherwise available to the public before the effective filing date. Any one limb is enough.
  • "On sale" does not require a completed sale, and since Helsinn v. Teva (2019) it does not require the sale to disclose anything: a confidential supply agreement can still put the invention on sale.
  • The § 102(b)(1) grace period forgives only disclosures made by an inventor, or by someone who got the subject matter from an inventor. A third party's independent publication is prior art against you from the day it appears.
  • The grace period is United States law. Under Article 54 EPC the state of the art is everything made available to the public before the filing date, and Article 55 excuses only six months, for abuse or an officially recognised international exhibition.

The statute is short enough to read. 35 U.S.C. § 102(a)(1) provides that a person is entitled to a patent unless "the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention". That is five independent triggers, and one is enough. Nothing in the sentence asks whether the disclosure was deliberate, whether it was commercially significant, or whether it was made by you.

What the bar is actually measuring

Two definitions do most of the work. The effective filing date is defined in § 100(i) as the actual filing date of the application containing the claim, or the earliest date the application is entitled to as a right of priority or benefit under §§ 119, 120, 121, 365 or 386. So a provisional application moves the date backwards for whatever it supports — which is the entire reason a provisional is worth filing early rather than well.

The second is geography, and the America Invents Act removed it. The Office states that public-use rejections under § 102(a)(1) may be based on uses that are public anywhere in the world, and that on-sale rejections may be based on sales or offers for sale without regard to where the sale activity took place. A demonstration in Shenzhen and a demonstration in Ohio now count identically.

Section 102(a)(1), taken apart

35 U.S.C. § 102(a)(1)

Five separate limbs, not one test with five factors. An act that fails four of them and satisfies the fifth still bars the patent.

The grace period is a United States rule, and that is the expensive part

Article 54(2) of the European Patent Convention defines the state of the art as "everything made available to the public by means of a written or oral description, by use, or in any other way, before the date of filing of the European patent application". There is no carve-out for the applicant's own disclosure. Article 55 gives the only relief, and it is not a grace period in any useful sense: six months, and only where the disclosure was due to an evident abuse against the applicant, or to display at an official or officially recognised international exhibition under the 1928 Paris exhibitions convention, with a certificate filed at the time of application.

Which means the order of operations decides everything. File first, and the Paris Convention does the rest: Article 4 gives twelve months of priority for patents, and Article 4B provides that a later filing in another member state "shall not be invalidated by reason of any acts accomplished in the interval, in particular, another filing, the publication or exploitation of the invention". Disclose first, and you have kept at most the United States.

One act, two clocks running at different speeds

  1. Day 0

    The disclosure happens

    Campaign goes live, booth opens, paper is published, first unit is offered.

  2. Day 0

    Absolute-novelty rights end

    In systems without a grace period the invention is now part of the state of the art.

  3. Months 1–12

    The US window is open

    Section 102(b)(1)(A) removes the disclosure from prior art — but only yours.

  4. Month 12

    The exception lapses

    File later and your own disclosure becomes prior art against your own claim.

The American clock is the one people watch. The foreign one has usually already stopped by the time anybody thinks to ask.

"On sale" does not need a sale, and since 2019 does not need a disclosure

This is the limb that catches people who were careful about everything else. The test comes from Pfaff v. Wells Electronics (1998) and is applied by the Office in two parts: the claimed invention must have been the subject of a commercial sale or offer for sale, not primarily for experimental purposes, and it must have been ready for patenting. An offer nobody accepted still satisfies the first part. A quotation that a customer could have turned into a binding contract by saying yes is an offer; a general advertisement usually is not.

The counterintuitive half arrived in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 586 U.S. 123 (2019). Helsinn had signed distribution agreements covering a specific dose of its drug, under terms requiring the counterparty to keep proprietary information confidential, more than a year before it filed. A unanimous Court held that "a commercial sale to a third party who is required to keep the invention confidential may place the invention 'on sale' under § 102(a)". Congress had reused settled statutory language, and the new catchall "otherwise available to the public" merely "captures material that does not fit neatly into the statute's enumerated categories" rather than narrowing the words in front of it.

What the grace period forgives, and who it forgives it for

Section 102(b)(1)(A) is the whole of the relief most inventors are relying on. Disclosures made one year or less before the effective filing date are not prior art under § 102(a)(1) if "the disclosure was made by the inventor or joint inventor or by another who obtained the subject matter disclosed directly or indirectly from the inventor or a joint inventor". Read the second half slowly. The exception is about the origin of the disclosure, not about its harmlessness. A journalist who wrote about your demo is covered because the subject matter came from you. A competitor who reached the same design independently is not.

Subparagraph (B) adds a shield with a sharp edge. Once you have publicly disclosed the subject matter, a later disclosure of that same subject matter by anyone else is also removed from prior art. The Office is clear that this only covers the same subject matter: where an intervening disclosure adds an element you never disclosed, that element remains available as prior art against you. Publishing first buys protection for exactly what you published and not one feature more.

Neither axis decides it alone

Where the disclosure came from

Timing before the effective filing date

One year or less

More than one year

You, or someone who got it from you

Excepted

Section 102(b)(1)(A) removes it. This is the only cell the grace period reaches.

Prior art

Your own disclosure now defeats your own claim. Nothing in the statute rescues this.

An independent third party

Prior art

Unless you had publicly disclosed the same subject matter first, in which case (B) removes it.

Prior art

Ordinary anticipation. The grace period was never about other people.

People check the calendar and stop. The origin of the disclosure is the axis that actually removes the reference, and it is the one nobody controls.

The five situations people are actually asking about

What you didWhich limb it engagesWhat it most likely costs
Launched a crowdfunding campaign describing the productPrinted publication or otherwise available; often on sale as well, where backers are buying a unitForeign novelty on day one; the US clock starts on the day the page goes live, not on the day it funds
Demonstrated a working unit at a trade showPublic use, where nobody watching was under an obligation of confidentialityThe same, and the fact that no one was allowed to handle it is not by itself a defence
Showed a pitch deck with no NDA in the roomOtherwise available to the public, to the extent the deck described the inventionDepends entirely on what the slides said; a problem statement is not a disclosure of a mechanism
Sold beta units to a handful of early customersOn sale — the offer alone is enough, and confidentiality does not save itThe strongest version of the bar, because the date is documented in your own invoices
Published a paper, poster or thesisPrinted publication, or the catchall — a thesis shelved in a university library qualifiesThe date is the date it became publicly accessible, which is often earlier than publication
None of these turns on intent. Each turns on a date and on whether anyone was under a confidentiality obligation.

The experimental-use qualifier in the Pfaff test is narrower than its name suggests: the sale or offer must not be primarily for experimental purposes, which is a question about the objective purpose of the activity rather than about whether you personally learned something from it. Selling units to see whether people will buy is market testing, not experimentation.

An NDA keeps a conversation out of "available to the public"

A disclosure made under a genuine obligation of confidence is generally not a public use or a public availability at all, which is why the Office frames the public-use enquiry around a showing made under no limitation, restriction or obligation of confidentiality. That is the practical answer for the conversations you cannot avoid before filing: investors, contract manufacturers, a machine shop, a co-founder you have not yet signed. A mutual or one-way NDA is the difference between a private meeting and a § 102(a)(1) event.

It is not a universal solvent, and Helsinn is the proof. Confidentiality answers the disclosure limbs; it does not answer "on sale". A non-disclosure agreement attached to a supply arrangement keeps the design secret and still leaves the commercial offer sitting in the prior art. If the meeting is about buying and selling rather than about evaluating, the NDA is not the document doing the work.

Put the confidentiality obligation in before the meeting

A signed NDA dated before the demo is what makes the demo private. Signed afterwards, it changes nothing about what was already made available to the public.

Open

The same instinct protects the fallback position. Anything you decide not to claim can remain a trade secret only for as long as it stays secret, and a disclosure that started a patent clock usually ended the trade secret at the same moment. Where the invention moves between entities — a spin-out, a licence, a technology transfer — make sure the contributors have signed an IP assignment before anyone relies on the priority date.

If it has already happened

The date is the asset now, and it is the thing most often reconstructed badly a year later. Establish it while the evidence is live rather than from memory in a deposition.

The record to build before you talk to anyone

  • The earliest date the invention was described publicly, and where — a campaign page, a post, a paper, a listing.
  • The earliest commercial offer, including quotations and purchase orders that were never accepted.
  • Every demonstration, with who was present and whether any confidentiality obligation covered them.
  • A copy of what was actually shown or said, not a description of it — the scope of the disclosure decides the scope of the damage.
  • Which foreign markets matter, since those rights are decided by the first date and not by the twelve-month one.

One more thing worth knowing before the panic sets in: a disclosure only bars what it disclosed. Section 102 is applied claim by claim. A campaign page that showed a finished housing may say nothing about the mechanism inside it, and a paper describing a result may not enable the method that produced it. The question is never "did I disclose the product" but "does the disclosure describe this claim".

What starts a clock and what ends a right

The grace period is not permission. It is a repair mechanism with a fixed expiry, available only for disclosures that trace back to you, and available only in one country. Treated as permission — as a year in which to launch, exhibit and take orders while deciding whether patents are worth it — it reliably converts a filing decision into a filing deadline nobody wrote down.

Which reduces to a single ordering rule that costs nothing to follow. The filing date is the only date that is fully within your control, and every other date in this article is measured against it. Move it earlier than the first conversation you cannot take back, and none of the rest of this applies.

General information, not legal advice. This guide explains how these documents and rules generally work. Law varies by jurisdiction and changes, and none of it is applied to your circumstances here. For anything consequential, consult a licensed attorney where you are.

Frequently asked

I launched on Kickstarter six months ago. Can I still get a US patent?

Possibly. Section 102(b)(1)(A) removes your own disclosure from prior art if the application is filed one year or less after it, so a US filing before the anniversary of the launch keeps the campaign from being used against you. Two caveats: an independent third-party disclosure in the meantime is not forgiven, and foreign rights in absolute-novelty systems were generally lost on the day the page went live.

Does an offer to sell count if nobody actually bought anything?

Yes. The test applied by the Patent and Trademark Office asks whether the invention was the subject of a commercial sale or offer for sale, not primarily experimental, and whether it was ready for patenting. A firm quotation the recipient could have accepted is an offer, and acceptance is not required. Advertising that invites negotiation rather than creating a contract is usually treated differently.

We only sold under NDA. Are we safe?

Not from the on-sale bar. In Helsinn Healthcare v. Teva the Supreme Court held unanimously that a commercial sale to a third party required to keep the invention confidential may place the invention on sale under § 102(a). Confidentiality answers the public-use and public-availability limbs of § 102(a)(1). It does not answer the sale limb, and Helsinn is the case that settled the point.

A competitor published the same idea after my demo. Does that hurt me?

It depends on what you disclosed first. Section 102(b)(1)(B) removes a later disclosure from prior art where the same subject matter had already been publicly disclosed by you, or by someone who obtained it from you. The Office reads "same subject matter" strictly: if the competitor's disclosure adds an element you never made public, that element remains available as prior art against your claim.

Does Europe have a one-year grace period like the United States?

No. Article 54(2) EPC treats as the state of the art everything made available to the public before the filing date, with no exception for the applicant's own acts. Article 55 excuses a disclosure only within six months, and only where it resulted from an evident abuse against the applicant or from display at an officially recognised international exhibition, which requires a certificate at filing.

Do the whole thing on your phone

Draft it, check it for risk, rewrite the clauses you do not like, sign it and send it — without opening a laptop.

  • 136 templates across 12 categories
  • AI review in plain English
  • Free every month — 3 documents, 2 reviews
Download on theApp Store
Free to download · no account

iPhone, iPad, Mac & Vision Pro · iOS 15.6+ · 76.1 MB
Premium from $1.99/week